When PSA is used to screen for prostate cancer, BMI must be taken into account to avoid misdiagnosis, especially in aged populations; however, when screening subjects older than 60 years, the PSA test may still be considered as an appropriate screening tool for prostate cancer in overweight and obese patients. The gene discussed is KLK3; the disease is prostate carcinoma.